Science
There Are Early Signals Ahead of Tafamidis Trial As Analysts See Potential Upside for Pfizer (PFE) and BridgeBio Pharma (BIO)
PharmaWire has reported on the tafamidis patent trial ahead of its scheduled court date on 27 April. Analysts have pointed to early signs that may be shaping expectations for Pfizer (NYSE: PFE), BridgeBio (NASDAQ: BBIO) and the broader ATTR-CM market.
UC Irvine Astronomers Gauge Livability of Exoplanets Orbiting White Dwarf Stars
Computer model comparison reveals rotational factors contributing to habitability.
NASA Announces Uncrewed Return of Boeing’s Starliner and Continuation of Astronaut Missions
Photo caption: NASA Administrator Bill Nelson and leadership host a live news conference on Saturday, Aug. 24, at the agency's Johnson Space Center in Houston to give a status update about NASA's Boeing Crew Flight Test.
Nuvectis Pharma Reports Q1 Results, Expects Several Clinical Updates in H2 2024
Nuvectis Chairman & CEO Ron Bentsur: “2024 is shaping up to be a potentially transformational year for Nuvectis with several clinical data updates expected in the second half of the year.”
Former NASA Space Shuttle Commander to Represent U.S. Industry at FIDAE 2024 Airshow
With largest international presence at the show, U.S. looks to advance a new century of cooperation with Chile.
Texas A&M Potato Breeding Program Highlights Market, Varietal Expansions
Advances, including Texas french fry variety and nutrition qualities, to be discussed at National Potato Expo in Austin.